Snowball logo
logo
ABNX_logo

Abionyx Pharma SA

ABNX β€’ PA
€1.956€0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
0.6755.2524.644.64.0629998.664
COGS
0.4164.6164.0223.73.6877.347
Gross Profit
0.2590.6360.6180.8440.3761.317
Operating Expenses & Income
Operating Income
(5.952)(4.109)(3.412)(5.572)(6.255)(11.18)
Total Operating Expenses
6.2114.7454.035.3096.63112.93
R&D Expenses
5.6772.5632.9022.9861.54.484
Selling General & Admin Expenses
0.5031.1881.1061.2864.4167.725
Earnings from Continuing Operations
Interest Expense
(0.124)(0.24)(0.019)(0.061)(0.2)(0.261)
Interest Income
0.0040.0060.060.1040.0130.053
Income Tax Expense
0.008(1.456)(1.384)(1.067)(0.688)(1.774)
Net Income
Net Income
(5.822)(4.206)(3.518)(4.4)(5.55)(9.925)
Supplemental
EBIT
(7.537)(4.145)(4.684)(5.406)(6.255)(11.03)
EBITDA
(7.418)(4.01)(4.531)(4.928)(5.704)(5.944)
In millions of EUR, except % and values per 1 share